ADMA Biologics Inc - Common Stock (NQ:ADMA)

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

August 10, 2026

From Faruqi & Faruqi, LLP

ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

Performance

52-Week Range 49.9% below 52-week high

10.26

7.2152W Low 20.4652W High

1 Week 0.9% below 1-week high

9.621W Low 10.351W High

ADMA Biologics Inc - Common Stock (ADMA) traded between $7.21 and $20.46 over the past 52 weeks and last traded at $10.26, 49.9% below its 52-week high. Over the past week it ranged between $9.62 and $10.35.

Past 12 Months

+2.2%

+7.5%

+11.3%

+10.7%

-42.6%

-27.1%

1W +$0.23

1M +$0.72

3M +$1.04

6M +$1.00

YTD -$7.62

1Y -$3.81

ADMA was -27.1% over the past year, +10.7% over six months, -42.6% year to date, +2.2% in the last week.

12 Months vs Market

ADMA

-27.1%

DIA

+9.4%

SPY

+15.6%

QQQ

+24.5%

IWM

+12.5%

Over the past 12 months ADMA returned -27.1% versus DIA (Dow) +9.4%, SPY (S&P 500) +15.6%, QQQ (Nasdaq 100) +24.5% and IWM (Russell 2000) +12.5%.

Volume & Liquidity 0.35× 3-mo avg

Today 925,278 3-mo avg 2.6M

3.0M

3.3M

2.6M

3.9M

YTD

4.2M

4.0M

ADMA most recently traded 925,278 shares against a 3-month average daily volume of 2.6M.

More News

August 09, 2026

ADMA Biologics 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

August 07, 2026

From Kahn Swick & Foti, LLC

ADMA BIOLOGICS CLASS ACTION DEADLINE AUGUST 10th: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

ADMA Biologics (NASDAQ:ADMA) Shares Slide as Q2 Results Miss Estimates ↗

August 05, 2026

Via Chartmill

August 07, 2026

From Bragar Eagel & Squire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 07, 2026

Via Newsfile

ADMA Biologics Deadline: Rosen Law Firm Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 07, 2026

From The Rosen Law Firm, P.A.

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

August 07, 2026

From SkyMedia, LLC

ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 06, 2026

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 06, 2026

From Schall, Brown & Schwartz LLP

ADMA Biologics Q2 Earnings Call Highlights ↗

August 05, 2026

Via MarketBeat

ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 05, 2026

From ADMA Biologics, Inc.

ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches

August 05, 2026

Via Newsfile

DEADLINE NEXT WEEK: Berger Montague Advises ADMA Biologics, Inc. (NASDAQ: ADMA) Investors to Contact the Firm Before August 10, 2026

August 05, 2026

From Berger Montague

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 04, 2026

From Kahn Swick & Foti, LLC

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

August 04, 2026

From Pomerantz LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)

August 04, 2026

From Bernstein Liebhard LLP

ADMA BIOLOGICS CLASS ACTION DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

August 03, 2026

From Bragar Eagel & Squire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 03, 2026

Via Newsfile

ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 03, 2026

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 03, 2026

From Schall, Brown & Schwartz LLP

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

July 31, 2026

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 31, 2026

Via Newsfile

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

July 31, 2026

From Lowey Dannenberg, P.C.